Cite

    Haroldsen, P. et al. (n.d.). Genetic variation in aryl N‐acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3, 4‐diaminopyridine) phosphate. Pharmacology research & perspectives. 3 (1), p. n/a. [Online].